Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Kanamycin Sulfate: Mechanism, Strategy, and Translational Vi
2026-05-06
This thought-leadership article explores Kanamycin Sulfate’s mechanistic action as a water-soluble aminoglycoside antibiotic, its pivotal application in modern microbiology and antibiotic resistance research, and strategic guidance for translational scientists. Integrating mechanistic detail, competitive context, and the latest advances in RNA bioprocessing, the article goes beyond protocol guides to map the future of robust, reproducible research.
-
VER 155008: HSP 70 Inhibitor Advances Apoptosis Assays in Ca
2026-05-06
VER 155008, a potent adenosine-derived HSP 70 inhibitor, empowers researchers to dissect chaperone-mediated pathways and apoptosis in cancer and neurodegeneration models. This guide translates recent mechanistic discoveries into actionable workflows, troubleshooting strategies, and optimized experimental parameters for superior assay performance.
-
Freeze-Induced Betaine Loading Boosts LNP mRNA Delivery Effi
2026-05-05
This study demonstrates that freezing lipid nanoparticles (LNPs) with the cryoprotectant betaine leads to its incorporation into LNPs through freeze concentration, significantly enhancing mRNA delivery efficacy. The work redefines the role of cryoprotectants, showing they can actively modulate LNP structure and function, opening new avenues for robust mRNA therapeutic development.
-
Dual-Action Kinase Inhibitors Modulate p38α Dephosphorylatio
2026-05-05
The referenced study reveals that certain kinase inhibitors can promote dephosphorylation of p38α MAP kinase by stabilizing its activation loop in a conformation accessible to phosphatases. This dual-action effect suggests new strategies to enhance the potency and specificity of kinase-targeted therapeutics by leveraging conformational control.
-
GANT61: Advanced GLI Inhibitor Workflows for Cancer Research
2026-05-04
GANT61 empowers precise inhibition of GLI1/GLI2, enabling researchers to dissect Hedgehog signaling and overcome tumor immune evasion. This guide details experimental workflows, protocol optimizations, and troubleshooting strategies to maximize the impact of GANT61 in translational cancer research.
-
Tamsulosin in Applied Urological Research: Protocols & Solut
2026-05-04
Leverage Tamsulosin's highly selective α₁A-adrenergic antagonism for advanced urological and smooth muscle research. This guide delivers stepwise protocols, assay-specific troubleshooting, and actionable insights—bridging clinical evidence with bench workflows and highlighting the practical impact of recent biomarker-driven findings.
-
Jasplakinolide: Actin Polymerization Inducer for Advanced Ce
2026-05-03
Jasplakinolide stands out as a benchmark actin polymerization inducer, enabling precise manipulation of cytoskeletal dynamics in live-cell studies. This guide delivers actionable workflows, troubleshooting insights, and a direct bridge from recent literature to optimized experimental design.
-
Anlotinib Hydrochloride: Redefining Multi-Target TKI Strateg
2026-05-02
This thought-leadership article explores how Anlotinib hydrochloride, a next-generation multi-target tyrosine kinase inhibitor, is reshaping translational cancer research through mechanistic precision and workflow-focused guidance. By bridging bench-to-bedside priorities, the piece delivers actionable insights for researchers seeking to leverage angiogenesis inhibition, with a strong emphasis on experimental validation, clinical relevance, and future outlook.
-
Drug-Sensitized Yeast Enhance mTOR Inhibitor Discovery Sensi
2026-05-01
This study introduces an engineered yeast platform with heightened sensitivity for detecting mTOR inhibitors, surpassing the limitations of traditional wild-type models. The system enables rapid, cost-effective screening, robustly distinguishing true TOR pathway inhibitors from unrelated compounds, and sets a new standard for early-stage drug discovery.
-
Ganetespib (STA-9090): Optimizing Hsp90 Inhibition in Cancer
2026-05-01
Ganetespib (STA-9090) delivers robust, selective Hsp90 inhibition, enabling rapid degradation of oncogenic proteins in diverse tumor models. This guide synthesizes advanced workflows, troubleshooting strategies, and innovative protocol enhancements—empowering researchers to maximize assay reproducibility and translational impact.
-
Tigecycline Workflows: Applied Strategies for MDR Bacteria R
2026-04-30
Tigecycline, a leading glycylcycline antibiotic, empowers researchers to model and combat multidrug-resistant pathogens in both in vitro and in vivo settings. This guide details experimental workflows, optimization tactics, and troubleshooting rooted in the latest resistance transmission research—transforming how labs approach challenging infection models.
-
Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi
2026-04-30
Anlotinib hydrochloride stands out as a next-generation multi-target tyrosine kinase inhibitor, enabling precise endothelial migration and tube formation assays. Its high selectivity and potency streamline anti-angiogenic research, offering superior reproducibility and actionable insights for cancer scientists.
-
Dovitinib (TKI-258, CHIR-258): Reliable RTK Inhibition for C
2026-04-29
This article presents scenario-driven guidance for leveraging Dovitinib (TKI-258, CHIR-258) (SKU A2168) in cell viability, proliferation, and cytotoxicity assays. It addresses common laboratory challenges and demonstrates how SKU A2168’s multitargeted RTK inhibition ensures reproducibility and robust data in oncology research.
-
Açaí Extracts: Cytotoxicity and Enzyme Induction in Hepatocy
2026-04-29
This study provides a detailed evaluation of the cytotoxic and enzyme/transporter induction potential of açaí (Euterpe oleracea) extracts in human hepatocytes. The findings highlight minimal risk for cytochrome P450 or transporter induction but reveal dose-dependent cytotoxicity for specific extract preparations, with implications for botanical-drug interaction assessment in translational research.
-
Danazol in Endocrine Axis Modeling: Mechanistic Depth and Tr
2026-04-28
Explore the scientific foundations and translational potential of Danazol in endocrine research. This article uncovers unique assay insights, mechanism-based applications, and real-world considerations for Danazol (Danocrine), advancing beyond typical protocols.
8371 records 17/559 page Previous Next First page 上5页 1617181920 下5页 Last page